Discuss techniques for treating cancer from genetic sequencing, reducing patient mortality, and warning about the possibility of developing cancer years in advance. This was the purpose of the seminar “Precision Medicine against Cancer”, sponsored by Folha de São Paulo on August 29th. The event was attended by professor and researcher Jorge Iriart (ISC / UFBA), who highlighted the unequal access to new technologies for cancer patients in the public sector.

Responsible for research that evaluates the impact of new treatments on society, conducted through interviews with oncologists and patients, the professor confirmed the frustration of doctors during the visits. “SUS patients and private hospitals have the same needs, but in the public system they do not have access to new technologies. Inequality causes a lot of frustration, ”he said.

Jorge Iriart also criticized the failure to comply with the 60-day law, the deadline for cancer patients to start treatment at the SUS, from the date of diagnosis. “This impairs the patient’s chances of healing,” he noted.

The professor also highlighted the entry of high cost drugs in the market, but with low benefit. “It’s happening all over the world, it’s a problem for developed countries too. They wonder how long they can afford to pay $ 100,000 a year [with these drugs].

To watch the full discussion video of the seminar “Precision Cancer Medicine”, click here.